Healthcare
Verdane sells CRF Health to Vitruvian
Exit comes two years after company was acquired in direct secondary
NeoMed leads CHF 20m Genkyotex financing
VI Partners and BioMedInvest are co-investors
SHS et al. invest in Vimecon
Existing and new investors also committed to latest funding round
Terra Firma's Four Seasons negotiates profits covenant waiver
GP bought the company for ТЃ825m almost three years ago
Sovereign acquires Nurse Plus from KCP
Deal marks an exit for KCP after just two and a half years
Oxford Tech in £2m round for Lightpoint
Several business angel networks also participated in the round
Waterland merges Median and RHM
GP acquired Median earlier this year for €1bn
Versant closes fund on $305m, makes European promotions
Principal Tom Woiwode has been promoted to managing director in firm's Basel office
Thuja et al. invest €6m in Cristal
Company will use funds to launch first clinical study of anti-cancer nanomedicine
Riverside's Orliman buys Soft Medical Europe
Riverside bought Orliman in 2011, anticipating a buy-and-build strategy
Calculus participates in £6m Collagen injection
Business has used the funding to buy New Zealand-based Southern Light
Elysian makes 2.6x return on IPS sale
Beechbrook Capital supplied mezzanine and equity investment
Alto invests in listed Novacyt
Company is listed on the Alternext Paris with a market cap of €33m
LDC's Quantum floats with £125m market cap
GP has retained an 8.2% shareholding following IPO
Optomeditech raises $2.5m from Lifeline and Sitra
Company is preparing for its commercial launch
Advent in partial exit from Mediq
GP took Mediq private for €775m at the beginning of 2013
Industrifonden in SEK 42m round for Glionova
Funding round brings total amount raised to nearly SEK 50m
Over the counter deals going over private equity's head
Given the high levels of pharmaceutical OTC deals witnessed in the corporate space this year, is PE missing out?
BioMedPartners and Grazia back Ayoxxa
Additional investment brings funding round to €11.3m
Ascendis completes $60m series-D
A total of seven investors comitted capital to the round
Seed Capital and Novo exit Contera
Exit includes future contingent and royalty payments clause
OEP acquires Duran Group
Vendor Adcuram bought company in 2005 in corporate carve-out
Ippon's Midatech to float
Ippon is currently the company's second-largest shareholder
Pieris raises fifth funding round
Company previously raised €43m in growth capital